Search

Publications
Abstract of flares of arthritis activity in children with JIA. Methods. Patients aged below 6 years with a diagnosis of JIA were recruited from the Rheumatology Clinical Database at the Royal Children's Hospital, Melbourne, Australia, from 1 January 2010 to 30 April

Tofacitinib for juvenile idiopathic arthritis.   [17-May-2022]

Murray G.M.; Renton W.D.
Abstract from the rheumatology database of paediatric rheumatology patients eligible for transition between January 2015 and September 2020. Result(s): One hundred and sixty-five patients were included; 57 patients were transitioned. Of patients transitioned

Trapeziometarpal joint arthritis in the young patient.   [18-Jan-2023]

Tham S.K.Y. ; McCombe D.B.
Abstract ) is likely to lead to progression of joint degeneration. In established arthritis, salvage procedures can successfully alleviate symptoms and return of function; however the long-term outcome of these procedures has not been determined

Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis.   [20-Jan-2022]

Renton W.D.; Tiller G.; Munro J.; Tan J.; Johnston R.V.; Avery J.C.; Whittle S.L.; Arno A.; Buchbinder R.
Abstract with clinically inactive juvenile idiopathic arthritis. This is a common protocol for two separate reviews: one on systemic onset juvenile idiopathic arthritis and one on non-systemic juvenile idiopathic arthritis. A secondary objective is to keep the evidence

Australian Paediatric Rheumatology Group standards of care for the management of juvenile idiopathic arthritis.   [7-Sep-2014]

Singh-Grewal D.; Munro J.; Murray K.; Boros C.; Chaitow J.; Allen R.C.; Akikusa J.; Adib N.; Piper S.E.
Abstract This standards document outlines accepted standards of management for children, adolescents and young adults with juvenile idiopathic arthritis (JIA) in Australia. This document acknowledges that the chronic inflammatory arthritis conditions (JIA

APRG member survey to identify priority questions for a living guideline for the pharmacological management of juvenile idiopathic arthritis.   [10-Jul-2021]

Tiller G.; Renton W.; Munro J.; Whittle S.; Avery J.; Johnston R.; Buchbinder R.
Abstract ) in order to develop a list of priority questions for an Australian guideline for the pharmacological management of juvenile idiopathic arthritis (JIA). We hypothesise that this will improve the relevance of the recommendations, leading to increased

The transition process for paediatric rheumatology clinic patients at a single tertiary paediatric rheumatology centre in Australia. [Internal Medicine Journal   [30-Jun-2022]

Huynh A.; Buckle J.; Cox A.; Czerniecki L.; Gowdie P. ; Renton W.; Allen R.; Tiller G.
Abstract from the rheumatology database of paediatric rheumatology patients eligible for transition between January 2015 and September 2020. Result(s): 165 patients were included. 57 patients were transitioned. 14 (33%) patients transitioned to adult
Abstract . This volume of submissions compares well with previous inquiries into health conditions, including a 2019 inquiry into paediatric and adult allergy (257 submissions), a 2015 inquiry into Hepatitis C (106 submissions) and a 2014 inquiry into skin cancer (63

Three and five year outcomes of an inception cohort of Australian children with juvenile idiopathic arthritis.   [30-Jun-2022]

Tiller G.; Hernandez B.; Buckle J.; Allen R.; Munro J.; Gowdie P. ; Cox A.; Akikusa J.
Journals
Title Arthritis and Rheumatology
Title Arthritis and Rheumatism
Title Arthritis research & therapy
Title Arthritis care & research
Title Arthritis Care and Research
Title Journal of Paediatrics and Child Health
Title J Paediatr Child Health
Title Paediatric Nursing skills for Australian Nurses